6 points, SCA Band 3, 0.125 EFTSL
Postgraduate - Unit
Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.
- First semester 2019 (On-campus)
- Second semester 2019 (On-campus)
Must be enrolled in a Postgraduate degree
Unit discontinuation and penalty dates for these units are different to other units taught in the same teaching period.
Please refer to the information available on the Faculty non standard teaching dates pageFaculty non standard teaching dates page (https://www.monash.edu/medicine/study/student-services/non-standard-dates) to avoid academic and financial penaltiesacademic and financial penalties (https://www.monash.edu/enrolments/change/add-or-discontinue-units).
This unit will examine case studies of medical biotechnology research and development, and will consider the industry context in which biotechnology is commercialised including: industry structure and competition; methods of financing, management approaches; the regulatory environment; product development and its commercial protection via intellectual property; and taking the product to market.
Students will examine case studies to analyse and evaluate the chances of commercialisation success of Australian companies in various phases of development, and present and justify their opinions in the form of class discussions, oral presentations and written business reports.
Upon successful completion of this unit, students will be able to;
- Interpret and critically evaluate the pathways from discovery science that lead to innovation and commercialisation of biotechnology innovations;
- Analyse and evaluate the critical role of intellectual property in the commercialisation of biotechnology;
- Apply advanced knowledge of how the major regulatory bodies [e.g. TGA (Therapeutic Goods Administration); FDA (Food & Drug Administration); CTN (Clinical Trial Notification Scheme)] deal with specific innovations in the biotech / medtech sectors;
- Evaluate and critically assess and predict the potential for commercial development and success of a specific biotechnology innovation;
- Systematically build and validate arguments and opinions by sourcing and critically deconstructing relevant material and information, working both independently and as part of a team;
- Effectively communicate complex concepts on scientific content and business processes in written or oral formats.
- 2 x Case study reports (4,500 words total) (55%) (hurdle)
- In-class worksheets (30%)
- Group oral presentation (15 minutes) (10%)
- Participation in workshop / class discussions (5%)
On-campus: 4-5 hours of contact per week, which will include a mix of presentations from industry experts and workshop activities.
Off campus: a minimum of 7-8 hours of private study, including preparation of work for discussion and assessment.
See also Unit timetable information